The new drugs advent: clinical or economic outcomes?

De Maio, E; Perrone, F; Bisagni, G; Boni, C

De Maio, E; Perrone, F; Bisagni, G; Boni, C.

Affiliation

De Maio E; Clinical Trials Unit, National Cancer Institute of Naples, Naples, Italy.

Ann Oncol ; 17 Suppl 2: ii88-90, 2006 Mar.

Article in En | MEDLINE | ID: mdl-16608995

Subject(s)

Antineoplastic Agents/economics; Carcinoma, Non-Small-Cell Lung/drug therapy; Lung Neoplasms/drug therapy; Antineoplastic Agents/therapeutic use; Carcinoma, Non-Small-Cell Lung/economics; Carcinoma, Non-Small-Cell Lung/mortality; Cost-Benefit Analysis; Economics, Pharmaceutical; Humans; Lung Neoplasms/economics; Lung Neoplasms/mortality; Medical Oncology; Survival Analysis

Search on Google

XML

PubMed Links

Database: MEDLINE Main subject: Carcinoma, Non-Small-Cell Lung / Lung Neoplasms / Antineoplastic Agents Type of study: Health_economic_evaluation Limits: Humans Language: En Year: 2006 Type: Article

Search on Google

XML

PubMed Links